Low-coverage whole-genome sequencing of cerebrospinal-fluid-derived  cell-free DNA in brain tumor patients - ScienceDirect

Low-coverage whole-genome sequencing of cerebrospinal-fluid-derived cell-free DNA in brain tumor patients - ScienceDirect

4.5
(601)
Write Review
More
$ 9.00
Add to Cart
In stock
Description

Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord

IJMS, Free Full-Text

Sequencing of cerebrospinal fluid cell-free DNA facilitated early differential diagnosis of intramedullary spinal cord tumors

Frontiers Cerebrospinal Fluid Cell-Free DNA-Based Detection of High Level of Genomic Instability Is Associated With Poor Prognosis in NSCLC Patients With Leptomeningeal Metastases

Cancers, Free Full-Text

Cerebrospinal fluid: A unique source of circulating tumor DNA with broad clinical applications - ScienceDirect

Frontiers Cerebrospinal Fluid Cell-Free DNA-Based Detection of High Level of Genomic Instability Is Associated With Poor Prognosis in NSCLC Patients With Leptomeningeal Metastases

PDF) The emerging role of cell-free DNA as a molecular marker for cancer management

Low-coverage whole-genome sequencing of cerebrospinal-fluid-derived cell-free DNA in brain tumor patients. - Abstract - Europe PMC

PDF) Cerebrospinal Fluid biomarkers in pediatric brain tumors: A systematic review

Biopsy‐free screening for glioma